Cenforce D is a prescription pharmaceutical combination product designed to address two of the most prevalent male sexual health concerns concurrently: erectile dysfunction and premature ejaculation. It contains two active pharmacological agents, Sildenafil Citrate and Dapoxetine, which work synergistically to improve erectile function and prolong intravaginal ejaculatory latency time. This medication is indicated for adult men experiencing both conditions and should be used under appropriate medical supervision following a thorough clinical assessment to ensure suitability and safety.

Features

• Contains Sildenafil Citrate (100mg), a PDE5 inhibitor
• Contains Dapoxetine (60mg), a selective serotonin reuptake inhibitor
• Film-coated tablet formulation for oral administration
• Requires a prescription from a licensed healthcare provider
• Manufactured in GMP-certified facilities
• Not intended for use by women or individuals under 18 years of age

Benefits

• Achieves and sustains firmer erections suitable for sexual activity
• Significantly delays ejaculation, improving sexual endurance and control
• Enhances overall sexual satisfaction for both partners
• Addresses two common dysfunctions with a single, coordinated treatment
• On-demand action allows for spontaneity, taken prior to anticipated sexual activity
• Clinically proven efficacy in improving sexual performance parameters

Common use

Cenforce D is prescribed for the treatment of men diagnosed with both erectile dysfunction (the consistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance) and premature ejaculation (persistent or recurrent ejaculation with minimal sexual stimulation before, on, or shortly after penetration and before the person wishes it). It is not intended for recreational use or for individuals without these diagnosed conditions. The medication is used on an as-needed basis approximately 1-3 hours prior to anticipated sexual activity.

Dosage and direction

The standard recommended dose is one tablet (Sildenafil Citrate 100mg / Dapoxetine 60mg) taken orally with a full glass of water. Do not break, crush, or chew the tablet. The medication should be taken approximately 1-3 hours before anticipated sexual activity. It may be taken with or without food, though a high-fat meal may delay the onset of action. Do not exceed one dose in a 24-hour period. The dosing schedule should be determined by a healthcare provider based on individual response and tolerability.

Precautions

• Inform your physician of any cardiovascular conditions, including angina, heart failure, or arrhythmias
• Disclose history of psychiatric disorders, including depression or anxiety
• Report any history of bleeding disorders or active peptic ulcer disease
• Avoid alcohol consumption as it may increase risk of adverse effects
• Use with caution in patients with hepatic impairment (moderate to severe) or severe renal impairment
• Not recommended for use with other treatments for erectile dysfunction or premature ejaculation
• May cause dizziness or syncope; avoid activities requiring alertness until effects are known
• Priapism (prolonged erection lasting more than 4 hours) requires immediate medical attention

Contraindications

• Hypersensitivity to Sildenafil Citrate, Dapoxetine, or any excipients
• Concurrent administration with nitrates or nitric oxide donors in any form
• Patients with severe hepatic impairment
• History of unstable angina, recent myocardial infarction, or stroke
• Patients with hereditary problems of galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption
• Concomitant use with strong CYP3A4 inhibitors
• Patients with significant pathological conditions affecting the retina
• History of mania or severe depression

Possible side effects

• Headache (common)
• Flushing (common)
• Nasal congestion (common)
• Dizziness (common)
• Nausea (common)
• Dyspepsia
• Visual disturbances (blurred vision, color tinge)
• Insomnia
• Dry mouth
• Diarrhea
• Fatigue
• Increased sweating
• Orthostatic hypotension
• Tachycardia
• Anxiety
• Less commonly: syncope, priapism, serotonin syndrome

Drug interaction

• Absolute contraindication with nitrates (e.g., nitroglycerin, isosorbide mononitrate)
• Contraindicated with strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir)
• Use with caution with alpha-blockers (risk of hypotension)
• Potential interaction with other PDE5 inhibitors
• May interact with other SSRIs or serotonergic drugs (risk of serotonin syndrome)
• Interaction with moderate CYP3A4 inhibitors (e.g., erythromycin) may require dose adjustment
• Potential interaction with antihypertensive medications
• Caution with drugs that prolong QT interval

Missed dose

As Cenforce D is taken on an as-needed basis rather than on a scheduled regimen, the concept of a “missed dose” does not apply. Do not take an extra dose to make up for a missed administration. Simply take the next dose when needed for sexual activity, ensuring at least 24 hours have passed since the last dose.

Overdose

In case of suspected overdose, seek immediate medical attention or contact a poison control center. Symptoms may include severe headache, severe dizziness, fainting, prolonged erection, nausea, vomiting, and cardiovascular effects. Treatment is supportive and symptomatic. Management of priapism may require urgent urological intervention. Hemodialysis is not expected to significantly enhance elimination of either component.

Storage

Store at room temperature (15-30°C or 59-86°F) in the original packaging. Protect from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Do not transfer tablets to other containers, as the original packaging provides protection from light and moisture.

Disclaimer

This information is for educational purposes only and does not constitute medical advice. Cenforce D is a prescription medication that should only be used under the supervision of a qualified healthcare professional. Individual results may vary. Always consult with a healthcare provider before starting any new medication to ensure it is appropriate for your specific medical condition and to discuss potential risks and benefits. Do not share your medication with others.

Reviews

Clinical studies demonstrate that combination therapy with Sildenafil and Dapoxetine provides statistically significant improvement in both erectile function and intravaginal ejaculatory latency time compared to placebo. Patients reported improved sexual satisfaction and confidence. The safety profile is consistent with the known profiles of the individual components when used separately. Real-world evidence supports the efficacy and tolerability of this combination approach in appropriately selected patients.